Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
Frontera Therapeutics logo

Frontera Therapeutics

Recent Finacing

Series B

Recent Raise

$160M

Frontera Therapeutics is a clinical-stage biotechnology company that develops and manufactures AAV-based gene therapies using the APEX platform and GMP manufacturing across ophthalmology, hematology, neurology, and metabolic disease areas.

Founded 2019
Massachusetts, United States
51-100
Private
fronteratherapeutics.com

Highlights

Focus Areas

Biotechnology

Recent Investors

Boyu Capital logo
Hongshan Capital Group (Sequoia Capital China) logo
OrbiMed logo
C

Financials

$160M

Total Raised

1

Funding round

4

Investors


Team

Upgrade to view the team

See the team members at Frontera Therapeutics.